Scholtz & Company’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,450
Closed -$509K 51
2023
Q4
$509K Buy
+1,450
New +$467K 0.25% 48
2022
Q1
Sell
-3,776
Closed -$1.56M 54
2021
Q4
$1.56M Buy
3,776
+366
+11% +$133K 0.51% 41
2021
Q3
$1.09M Sell
3,410
-120
-3% -$39K 0.39% 42
2021
Q2
$1.04M Buy
3,530
+758
+27% +$217K 0.36% 47
2021
Q1
$766K Buy
2,772
+939
+51% +$243K 0.29% 47
2020
Q4
$479K Buy
1,833
+437
+31% +$105K 0.19% 55
2020
Q3
$315K Buy
1,396
+417
+43% +$95.5K 0.14% 57
2020
Q2
$210K Buy
+979
New +$185K 0.1% 56
2020
Q1
Sell
-1,600
Closed -$337K 51
2019
Q4
$337K Buy
+1,600
New +$312K 0.2% 52

Other funds holding ACN

Scholtz & Company's ACN Position: Q1 2024 in Review

Scholtz & Company sold out of Accenture (ACN) in Q1 2024, closing a stake of 1,450 shares — an estimated $509K sold.

Scholtz & Company first reported a position in ACN in Q4 2019 and held it in 9 quarters. The position peaked at $1.56M in Q4 2021. 2,342 funds tracked by Wall St. Rank hold ACN as of Q1 2024.

  • Scholtz & Company reported no remaining Accenture position as of Q1 2024 after selling out during the quarter.
  • Scholtz & Company sold 1,450 Accenture shares in Q1 2024, an estimated $509K.
  • Scholtz & Company first reported a position in Accenture in Q4 2019 and held it in 9 quarters.
  • Scholtz & Company's Accenture position peaked at $1.56M in Q4 2021.
  • 2,342 funds tracked by Wall St. Rank held Accenture as of Q1 2024.

Based on Scholtz & Company's 13F filing for Q1 2024, filed 14 May 2024.